REVIEW PAPER
Metallothioneins and its role in metal regulation, binding of reactive oxygen species, apoptosis and cell differentiation
 
More details
Hide details
1
Department of Environmental Hygiene, Institute of Agricultural Medicine, Lublin, Poland
 
J Pre Clin Clin Res. 2007;1(1):16–18
KEYWORDS
ABSTRACT
Metallothioneins (MT) are the widespread proteins in animal world. These proteins are characterized by the low invariability of their structure. The number of aminoacids is fixed in every animal group, that is 60 (or 61) aminoacids, 20 of which are the cysteins radicals what makes over 30% of the aminoacid composition. Such a big ammount of cysteins which include the reactive sulfhydryl groups -SH determinates the metallothionein’s functions. Metallothionein take part in the homeostasis of the ions of the metals which are necessary for the proper metabolism of the organism (zinc, copper), and they also take part in the detoxication of the tissue from toxic metals. Apart from these they also protect the tissue from the reactive oxygen species. Metallothioneins are present in high concentration in fast-dividing and transformating cells. Experiments indicate that MT involvement in the process of cell proliferation and differentiation. The presence in MT molecules of a large number of thiolic groups with nucleophilic properties renders them capable of binding not only metallic cathions but also reactive oxygen species and organic radicals (loose electron couples beside a suphur atom easily bind with elements having an electron hole). Numerous studies point out an MT influence on the process of apoptosis.
 
REFERENCES (20)
1.
Huang PC: Metallothionein structure/function interface. In: Metallothionein III: Biological Roles and Medical Implications. (Eds): Suzuki KT, Imura N, Kimura M, Birkhauser Verlag, Basel, 1993, 407-426.
 
2.
Bremner J, Beattie JH: Metallothionein and the trace metals. Ann Rev Nutr 1990, 10, 63-83.
 
3.
Chan H, Cherian MG: Mobilization of hepatic cadmium in pregnant rats. Toxicol Appl Pharmacol 1993, 120, 308-314.
 
4.
Adrews PA, Howell SB: Cellular pharmacology of cisplatin: perspectives on mechanism of acquired resistance. Cancer Wells 1990, 2, 35-43.
 
5.
Floriańczyk B: Czynniki indukujące syntezę metalotionein. Post Hig Med Dośw 2000, 5, 687-697.
 
6.
Floriańczyk B, Osuchowski J, Kaczmarczyk R, Trojanowski T: Metallothionein and magnesium concentration in the brain tumours. Polish J Environ Stud 2006, 15, 33.
 
7.
Floriańczyk B, Grzybowska L: Concentration of metallothionein and microelements in breast cancer. Polish J Environ Stud 2006, 15 (2a), 69.
 
8.
Kelly SL, Basu A, Teicher BA, Hacker MP, Hamer DH, Lazo LS: Overexpression of metallothionein confers resistance to anticancer drugs. Science 1988, 24, 1813-1815.
 
9.
Roesijadi G: Metallothionein and its role in toxic metal regulation. Comp Biochem Physiol 1996, 11(3C), 117-123.
 
10.
Floriańczyk B: Zinc and metallothioneins in the cancer. Ann UMCS Sectio D 2003, 48, 102-105.
 
11.
Philcox JC, Tilley MH, Coyle P: Metallothionein and zinc homeostasis during tumor progression. Biol Trace Elem Res 1994, 40, 295-308.
 
12.
Thiele DJ: Metal-regulated transcription in eukaryotes. Nucleic Acids Res 1992, 20, 1183-1191.
 
13.
Palmiter RD: Regulation of metallothionein genes by heavy metals ,appears to be mediated by a zinc-sensitive inhibitor that interacts with a constitutively active transcription factor MTF-1. Proc Natl Acad Sci USA 1994, 91, 1219-1223.
 
14.
Sewell AK, Jensen LT, Erickson JC, Palmiter RD, Winge DR: The bioactivity of metallothionein-3 correlates with its novel β domain sequence rather than metal binding properties. Biochemistry 1995, 34, 4740-4747.
 
15.
Campagne MV, Thibodeaux H, Van Bruggen N, Cairns B, Lowe DG: Increased binding activity at an antioxidant-responsive element in the metallothionein-1 promoter and rapid induction of metallothionein-1 and -2 in response to cerebral ischemia and reperfusion. J Neurosci 2000, 15, 5200-5207.
 
16.
Deng DX, Chakrabarti S, Waalkes MP, Cherian MG: Metallothionein and apoptosis in primary human hepatocellular carcinoma and metastatic adenocarcinoma. Histpathology 1998, 32, 340-347.
 
17.
Kondo Y, Rusnak J.M, Hoyt DG, Settineri CE, Pitt BR, Lazo JS: Enhanced apoptosis in metallothionein null cells. Mol Pharmacol 1997, 52, 195-201.
 
18.
Abdel-Mageed AB, Agrawal KC: Activation of nuclear factor kappa B: potential role in metallothionein-mediated mitogenic response. Cancer Res 1998, 58, 2335-2338.
 
19.
Tsuikawa K, Imai T, Kakutani M: Localization of metallothionein in nuclei of growing primary cultured adult rat hepatocytes. FEBS Lett 1991, 283, 239-242.
 
20.
Tsujikawa K, Suzuki N, Sagawa K, Itoh M, Suguyama T, Kohama Y, Otaki N, Kimura M, Mimura: Induction and subcellular-localization of metallothionein in regenerating rat-liver. Eur J Cell Biol 1994, 63, 240-246.
 
eISSN:1898-7516
ISSN:1898-2395